Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Deferred Tax Assets / Liabilities ₹6.31 Cr₹4.98 Cr₹4.42 Cr₹4.58 Cr₹7.16 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹6.31 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹6.31 Cr
Mar2024₹4.98 Cr
Mar2023₹4.42 Cr
Mar2022₹4.58 Cr
Mar2017₹7.16 Cr

How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹6.31 Cr
26.80
Mar2024 ₹4.98 Cr
12.55
Mar2023 ₹4.42 Cr
-3.34
Mar2022 ₹4.58 Cr
-36.07
Mar2017 ₹7.16 Cr -

Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,276.5 Cr 15.8% 14.5% -26.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

15.8%

14.5%

-26.8%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses